LFST Maintains Overweight by Barclays -- Price Target Raised to $15.00

gurufocus.com · 2026-09-10

On October 10, 2023, LifeStance Health Group Inc (LFST) received a positive analyst rating update from Barclays. Analyst Peter Warendorf has maintained an Overw

TickrTrends take: Barclays' overweight rating and raised price target of $15 suggest analyst confidence in LFST's fundamental prospects within the Healthcare sector. With TickrTrends currently awaiting a full valuation assessment, investors focused on valuation metrics should monitor whether the company's underlying financials and growth trajectory support a move toward that $15 target level. The analyst upgrade provides a benchmark that valuation-oriented readers can reference as more comprehensive pricing data becomes available.

Read the full story at gurufocus.com →